Loading…
Loading…
Johnson & Johnson
NYSE · Stock Profile · Market Cap $571.68B
Current Price
$237.28
-0.35%GoodMoat Value
$253.80
7.0% undervaluedFree cash flow has been growing at 27.2% annually.
Forward estimates use 27.2% FCF growth (CAGR)
Net Debt: 28.2B
22.4B
FY24
22.5B
FY24
88.8B
FY24
21.9B
FY25
23.7B
FY25
24.0B
FY25
94.2B
FY25
4.7B
FY24
2.7B
FY24
14.1B
FY24
11.0B
FY25
5.5B
FY25
5.2B
FY25
26.8B
FY25
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New Jersey, USA
Free cash flow has been growing at 27.2% annually.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
2.17%
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
New Jersey, USA